Dose tailoring of anti‐tumour necrosis factor‐alpha therapy delivers useful clinical efficacy in Crohn disease patients experiencing loss of response
暂无分享，去创建一个
J. Andrews | I. Lawrance | A. Sechi | S. Connor | S. Ghaly | M. Sparrow | A. Walsh | L. Beswick | B. Headon | A. Pudipeddi | S. Costello | A. Agarwal | S. Antoniades | Jane M. Andrews | Samuel P Costello | Susan J. Connor | Alissa Walsh | Lauren Beswick | Aditya Agarwal | Miles P. Sparrow | A. Pudipeddi